Document is current
Any future updates will be listed below
-
Authors
Grunow, Julius J. https://orcid.org/0000-0003-4164-0138
Hartmann, Leonie
Ulm, Bernhard
Maechler, Mathilde
Blobner, Manfred
Seidenspinner, Katharina
Schoennagel, Lukas
Weber-Carstens, Steffen
Fuest, Kristina
Wollersheim, Tobias
Schaller, Stefan J. https://orcid.org/0000-0002-6683-9584
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03785444 at ClinicalTrials.govDocuments that mention this clinical trial
Reliability of pre-admission patient-reported outcome measures postoperatively assessed via proxies: a prospective, multicenter observational study
https://doi.org/10.1186/s13054-025-05431-6
-
Funding
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Received: 16 February 2025
Accepted: 23 April 2025
First Online: 19 May 2025
Declarations
:
: This study was approved by the institutional ethics committee of the medical faculty of the Technical University of Munich (542/18S) and conducted at Charité-Universitätsmedizin Berlin and Klinikum rechts der Isar of the Technical University of Munich according to the declaration of Helsinki. It was registered at ClinicalTrials.gov (NCT03785444—28 th of December 2018). All patients gave written informed consent to participate.
: Not applicable.
: JJG, LH, BU, MM, KS, LS, SWC, KF and TW have no conflict of interest to declare. MB participated in a DSMB sponsored by GE Healthcare, Helsinki, Finland. SJS received grants and non-financial support from Reactive Robotics GmbH (Munich, Germany), ASP GmbH (Attendorn, Germany), STIMIT AG (Biel, Switzerland), ESICM (Geneva, Switzerland), grants, personal fees, and non-financial support from Fresenius Kabi Deutschland GmbH (Bad Homburg, Germany), grants from the Innovationsfond of The Federal Joint Committee (G-BA), personal fees from Springer Verlag GmbH (Vienna, Austria) for educational purposes and Advanz Pharma GmbH (Bielefeld, Germany), non-financial support from national and international societies (and their congress organisers) in the field of anesthesiology and intensive care medicine, outside the submitted work. Dr. Schaller holds stocks in small amounts from Alphabet Inc., Ascendis Pharma Inc., Bayer AG, and Siemens AG; these holdings have not affected any decisions regarding his research or this study.
